Skip to main content

PSS, EliTech Ink Deal for IVD Tests

NEW YORK (GenomeWeb News) – Precision System Science today announced an agreement to optimize and implement EliTech Group's Elite MGB Real-Time PCR technology as human in vitro diagnostic tests on the PSS geneLead system.

Financial and other terms of the joint development, distribution, and supply agreement were not disclosed.

Based in Matsudo, Japan, PSS has combined its automated DNA extraction technology with PCR and multifluorescence assay detection methods to develop real-time PCR analyzers. In December, it announced a partnership with Roche to develop a PCR-based instrument for sample preparation in next-generation sequencing workflows.

The geneLead system, it said, is broadly applicable for DNA and RNA diagnostic testing, including infectious disease, oncology, and human genetic testing.

EliTech, based in Puteaux, France, has developed PCR assays for infectious disease, oncology, and human genetics applications. Last summer, it received US Food and Drug Administration clearance for its real-time PCR assay for the detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA.

"The combination of PSS unique expertise in systems development, in particular molecular diagnostics, and EliTech's unique IP portfolio and broad range of assays will deliver a timely, attractive molecular platform," said EliTech CEO Pierre Debiais in a statement.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.